Rystiggo 280 mg/2 ml, solution injectable
7680692270016
CH-69227
Injektionslösung
Associated product:
RYSTIGGO sol inj 280 mg/2ml flac 2 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
rozanolixizumabum
|
280.0 MG | Substance | Wirkstoff (Principe actif) |
|
histidinum
|
- | Substance | HNIDK |
|
histidini hydrochloridum monohydricum
|
- | Substance | HNIDK |
|
prolinum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
UCB-Pharma SA
1630 Bulle
Authorization information
- Swissmedic authorization number
- 69227
- Drug name
- Rystiggo, solution injectable
- Galenic form
- LSINJ
- ATC Code
- L04AG16
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 12/02/2025
- Authorization expiration date
- 11/02/2030
- IT Number
- 07.15.0.
- Domain
- Human medicine
Package details
- Description (FR)
- RYSTIGGO sol inj 280 mg/2ml flac 2 ml
- Description (DE)
- RYSTIGGO Inj Lös 280 mg/2ml Durchstf 2 ml
- Market launch
- 12/02/2025
- Narcotic (BTM)
- No
Other package sizes (1)
None
1 DUR
GTIN: None